| scholarly article | Q13442814 |
| P50 | author | Brian D. Lowes | Q39486752 |
| P2093 | author name string | JoAnn Lindenfeld | |
| Michael R Bristow | |||
| Mark Geraci | |||
| Eugene E Wolfel | |||
| Joseph Cleveland | |||
| Michael Reed | |||
| Andreas Brieke | |||
| Ronald Zolty | |||
| Norman Gray | |||
| Simon F Shakar | |||
| Wayne Minobe | |||
| Mihail Calalb | |||
| P2860 | cites work | Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy | Q24306812 |
| Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading | Q28216246 | ||
| Left ventricular assist device and drug therapy for the reversal of heart failure | Q28271792 | ||
| TSGA10 prevents nuclear localization of the hypoxia-inducible factor (HIF)-1alpha | Q28510604 | ||
| Specific beta1-adrenergic receptor silencing with small interfering RNA lowers high blood pressure and improves cardiac function in myocardial ischemia | Q28583422 | ||
| The gene expression fingerprint of human heart failure | Q30476199 | ||
| Thyroid hormone and the cardiovascular system | Q31921377 | ||
| Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group | Q33893139 | ||
| Long-term use of a left ventricular assist device for end-stage heart failure. | Q34109624 | ||
| Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes | Q34243039 | ||
| The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes | Q34248415 | ||
| Inflammatory mediators and the failing heart: past, present, and the foreseeable future | Q35011415 | ||
| Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray | Q35747980 | ||
| Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes | Q36197615 | ||
| Remodeling of the heart in chronic pressure overload | Q36384012 | ||
| LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery | Q36453687 | ||
| Serial gene expression profiling in the intact human heart | Q37258938 | ||
| Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. | Q37374337 | ||
| Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling | Q38304283 | ||
| Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction | Q40920382 | ||
| Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences | Q42274707 | ||
| The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group | Q42556789 | ||
| Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study | Q43558666 | ||
| Metabolic gene expression in fetal and failing human heart | Q43819742 | ||
| Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure | Q43961153 | ||
| Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents | Q43977844 | ||
| Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway | Q44019897 | ||
| Hypoxia-induced switches of myosin heavy chain iso-gene expression in rat heart. | Q44395850 | ||
| Depressed cardiac tension cost in experimental diabetes is due to altered myosin heavy chain isoform expression | Q44786795 | ||
| The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling | Q44829171 | ||
| Pressure-induced regulation of myosin expression in rodent heart | Q44969121 | ||
| Thin-filament-based modulation of contractile performance in human heart failure | Q45012605 | ||
| Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial. | Q45037067 | ||
| Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban | Q45863016 | ||
| Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart | Q46534000 | ||
| Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support | Q46701008 | ||
| Differential gene expression and genomic patient stratification following left ventricular assist device support | Q47990565 | ||
| Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support | Q49142828 | ||
| Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. | Q51355859 | ||
| Influence of prolonged ventricular assistance on myocardial histopathology in intact heart | Q70928470 | ||
| Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device | Q71038269 | ||
| The effect of load on atrophy, myosin isoform shifts and contractile function: studies in a novel rat heart transplant preparation | Q72262217 | ||
| Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure | Q73230419 | ||
| Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays | Q73306462 | ||
| Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression | Q73549977 | ||
| Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy | Q73558482 | ||
| Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts | Q74397788 | ||
| Comparison of exercise performance in patients with chronic severe heart failure versus left ventricular assist devices | Q77319721 | ||
| Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure | Q77361698 | ||
| Left ventricular assist devices and the failing heart: a bridge to recovery, a permanent assist device, or a bridge too far? | Q77614521 | ||
| Atrophy of myocardium and its myocytes by left ventricular assist device | Q78197916 | ||
| Phospholamban ablation by RNA interference increases Ca2+ uptake into rat cardiac myocyte sarcoplasmic reticulum | Q80532852 | ||
| Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy | Q83048014 | ||
| HIF-1: hypoxia-inducible factor or dysoxia-inducible factor? | Q83289607 | ||
| Specific and sustained down-regulation of genes involved in fatty acid metabolism is not a hallmark of progression to cardiac failure in mice | Q83333541 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 1170-1176 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | The Journal of Heart and Lung Transplantation | Q2364382 |
| P1476 | title | Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers | |
| P478 | volume | 26 |
| Q51944941 | CELF-mediated alternative splicing is required for cardiac function during early, but not later, postnatal life. |
| Q47096841 | Hypoxia favors myosin heavy chain beta gene expression in an Hif-1alpha-dependent manner. |
| Q37995890 | Is myocardial recovery possible and how do you measure it? |
| Q38792510 | Left ventricular assist device-induced reverse remodeling: it's not just about myocardial recovery |
| Q36065639 | Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects |
| Q49686229 | Right ventricular involution: What can we learn from nature's model of compensated hypertrophy? |
| Q39156232 | Targeted myocardial gene expression in failing hearts by RNA sequencing |
| Q38223705 | The Notch pathway: a novel target for myocardial remodelling therapy? |
| Q28081504 | The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors |
| Q38294845 | β-myosin heavy chain is induced by pressure overload in a minor subpopulation of smaller mouse cardiac myocytes |
Search more.